Stock Market Reviews

GDRX (GoodRx Holdings, Inc.) News

Get the latest news, insights, and market updates on GDRX (GoodRx Holdings, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• GoodRx’s (NASDAQ:GDRX) Q3 Sales Top Estimates
  Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $196 million. Its non-GAAP profit of $0.08 per share was 12.3% below analysts’ consensus estimates.
  Nov 4, 2025 - $GDRX
• GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings Estimates
  GoodRx (GDRX) delivered earnings and revenue surprises of -11.11% and +1.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 4, 2025 - $GDRX
• GoodRx Reports Third Quarter 2025 Results
  SANTA MONICA, Calif., November 04, 2025--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the third quarter of 2025.
  Nov 4, 2025 - $GDRX
• GoodRx (GDRX) Q3 Earnings Report Preview: What To Look For
  Healthcare tech company GoodRx (NASDAQ:GDRX) will be reporting earnings this Tuesday after market close. Here’s what to expect.
  Nov 3, 2025 - $GDRX
• Zura Bio And 2 Other Promising Penny Stocks For Your Watchlist
  As U.S. stock indexes hit record highs amid optimism over trade discussions between the U.S. and China, investors are increasingly looking for opportunities beyond the major indices. Penny stocks, often associated with smaller or newer companies, remain a relevant investment area despite their somewhat outdated label. These stocks can offer significant growth potential when backed by strong financials, and we will explore several that stand out as promising candidates for those seeking hidden...
  Oct 28, 2025 - $GDRX
• Nautilus Biotechnology And 2 Other Promising Penny Stocks
  As major U.S. stock indexes continue to set fresh records, investors are closely watching the Federal Reserve's latest moves and the potential impact on market trends. In this context, penny stocks—often representing smaller or newer companies—remain an intriguing investment area despite their somewhat outdated name. This article will explore three such stocks that stand out for their financial strength and potential to offer compelling opportunities in today's market landscape.
  Oct 28, 2025 - $GDRX
• GoodRx Launches New ‘GoodRx for Hair Loss’ Subscription Service for Men
  GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the best NASDAQ stocks under $5 to buy now. On October 15, GoodRx announced the launch of a new subscription service called GoodRx for Hair Loss designed to simplify access to affordable treatment for men. The subscription is an all-in-one solution for a health concern that affects about […]
  Oct 26, 2025 - $GDRX
• 3 Promising Penny Stocks With Market Caps Over $700M
  Major stock indexes in the United States recently ended lower as investors grappled with earnings reports and renewed U.S.-China trade tensions. Despite these challenges, penny stocks remain an intriguing investment option for those seeking growth opportunities in smaller or newer companies. While the term "penny stocks" might seem outdated, these investments can still offer surprising value when backed by strong financials, providing a potential mix of stability and long-term potential.
  Oct 23, 2025 - $GDRX
• Undervalued Penny Stocks To Watch In October 2025
  As the U.S. stock market experiences gains amid trade news with China and a surge in oil futures, investors are keeping a close eye on emerging opportunities. Penny stocks, despite their somewhat outdated label, remain an intriguing area for those interested in smaller or newer companies that might offer untapped potential. These stocks can provide growth opportunities at lower price points when supported by strong financials and sound fundamentals.
  Oct 23, 2025 - $GDRX
• GoodRx (GDRX): Buy, Sell, or Hold Post Q2 Earnings?
  Over the past six months, GoodRx’s stock price fell to $3.94. Shareholders have lost 9.8% of their capital, which is disappointing considering the S&P 500 has climbed by 30.6%. This was partly due to its softer quarterly results and might have investors contemplating their next move.
  Oct 21, 2025 - $GDRX